Synaptojanin 2 Protein

Synaptojanin 2 Protein

Introduction

Synaptojanin 2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@mcpherson2016]
<div class="infobox-header">Protein Information</div> [@berman2008]
<table class="infobox-table"> [@islam2020]
<tr><th>Protein Name</th><td><strong>Synaptojanin 2</strong></td></tr> [@verstreken2009]
<tr><th>Gene</th><td><a href="/genes/synj2">SYNJ2</a></td></tr>
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/Q9QUH5">Q9QUH5</a></td></tr>
<tr><th>PDB Structure</th><td>6OMN, 6OML (Cryo-EM structures)</td></tr>
<tr><th>Molecular Weight</th><td>175 kDa ( amino1573 acids)</td></tr>
<tr><th>Subcellular Location</th><td>Presynaptic terminals, [dendritic spines](/cell-types/dendritic-spines), endocytic compartments</td></tr>
<tr><th>Protein Family</th><td>Inositol Polyphosphate 5-Phosphatase Family</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

Synaptojanin 2 Protein

Introduction

Synaptojanin 2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@mcpherson2016]
<div class="infobox-header">Protein Information</div> [@berman2008]
<table class="infobox-table"> [@islam2020]
<tr><th>Protein Name</th><td><strong>Synaptojanin 2</strong></td></tr> [@verstreken2009]
<tr><th>Gene</th><td><a href="/genes/synj2">SYNJ2</a></td></tr>
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/Q9QUH5">Q9QUH5</a></td></tr>
<tr><th>PDB Structure</th><td>6OMN, 6OML (Cryo-EM structures)</td></tr>
<tr><th>Molecular Weight</th><td>175 kDa ( amino1573 acids)</td></tr>
<tr><th>Subcellular Location</th><td>Presynaptic terminals, [dendritic spines](/cell-types/dendritic-spines), endocytic compartments</td></tr>
<tr><th>Protein Family</th><td>Inositol Polyphosphate 5-Phosphatase Family</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

Synaptojanin 2 (SYNJ2) is a neuronal phosphoinositide phosphatase critical for synaptic vesicle endocytosis and membrane trafficking in the brain. While SYNJ1 has been extensively studied for its role in presynaptic vesicle recycling, SYNJ2 performs distinct functions in both pre- and postsynaptic compartments. SYNJ2 dephosphorylates phosphoinositides including phosphatidylinositol-4,5-bisphosphate (PI(4,5)P₂) and phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P₃), thereby regulating clathrin-mediated endocytosis, synaptic vesicle uncoating, and postsynaptic receptor trafficking[@cremona1999].

Structure

Domain Architecture

SYNJ2 contains several distinct functional domains:

• N-terminal Sac1 domain (residues 1-400): Catalytic domain with PI4P phosphatase activity
• Central 5-phosphatase domain (residues 650-900): Primary catalytic activity for PI(4,5)P₂ and PI(3,4,5)P₃
• C-terminal proline-rich region (PRD): Protein-protein interactions via SH3 domain binding
• C2 domains: Calcium-dependent membrane association

Isoforms

The SYNJ2 gene produces multiple isoforms:

• SYNJ2a: [Neuron](/entities/neurons)-specific isoform with presynaptic localization
• SYNJ2b: Broader expression including immune cells and cancer cells

Molecular Function

Phosphoinositide Phosphatase Activity

SYNJ2 catalyzes the dephosphorylation of several phosphoinositides:

This phosphatase activity is essential for synaptic vesicle recycling and postsynaptic receptor endocytosis[@mcpherson2016].

Role in Synaptic Vesicle Endocytosis

SYNJ2 functions at multiple stages of the synaptic vesicle cycle:

Postsynaptic Functions

In [dendritic spines](/mechanisms/dendritic-spines), SYNJ2 regulates:

• AMPA Receptor Endocytosis: Controls synaptic strength through receptor trafficking
• [NMDA Receptor](/entities/nmda-receptor) Trafficking: Modulates synaptic plasticity
• Dendritic Spine Morphogenesis: Regulates spine development and maintenance
• Long-term Depression (LTD): Mediates activity-dependent synaptic weakening

Brain Expression and Localization

Regional Expression

SYNJ2 is highly expressed in:

• Cerebral [cortex](/brain-regions/cortex) (especially Layer 2/3 pyramidal neurons)
• [Hippocampus](/brain-regions/hippocampus) (CA1 region, dentate gyrus)
• Basal ganglia (striatum, substantia nigra)
• Cerebellum (Purkinje cells)

Subcellular Localization

• Presynaptic terminals (active zones)
• Dendritic spines (postsynaptic densities)
• Endocytic compartments (early endosomes, recycling endosomes)
• Growth cones during development

Disease Associations

Alzheimer's Disease

SYNJ2 is implicated in Alzheimer's disease pathogenesis through several mechanisms:

• Synaptic Dysfunction: Altered expression in AD brain correlates with cognitive decline
• Amyloid Interaction: PI(4,5)P₂ metabolism affected by amyloid-β toxicity
• [Tau](/proteins/tau) Pathology: Phosphoinositide signaling dysregulated in tauopathy
• Therapeutic Target: SYNJ2 inhibitors being explored to enhance synaptic function[@berman2008]

Parkinson's Disease

SYNJ2 plays important roles in PD:

• Dopaminergic Neuron Function: Critical for vesicle cycling in substantia nigra pars compacta
• LRRK2 Interaction: SYNJ2 phosphorylation regulated by LRRK2 kinase activity
• [α-Synuclein](/proteins/alpha-synuclein) Pathology: Endocytic dysfunction contributes to protein aggregation
• Genetic Association: SYNJ2 variants linked to PD risk[@islam2020]

Epilepsy

SYNJ2 is indirectly targeted by antiepileptic drugs:

• SV2 Modulation: Levetiracetam binds synaptic vesicle protein 2 (SV2)
• Synaptic Transmission: Altered vesicle cycling affects seizure threshold

Cancer

Beyond neurodegeneration, SYNJ2 has roles in:

• Cell Migration: PI(3,4,5)P₃ phosphatase activity affects cytoskeletal dynamics
• Tumor Progression: Elevated expression in certain cancers

Therapeutic Implications

Drug Development

SYNJ2 is an emerging therapeutic target:

| Approach | Description | Development Stage |
|----------|-------------|-------------------|
| Small Molecule Inhibitors | Block phosphatase activity to enhance synaptic function | Preclinical |
| Gene Therapy | Viral vector delivery to restore SYNJ2 expression | Research |
| Modulator Development | Allosteric modulators of SYNJ2 activity | Early Discovery |

Research Tools

• Activity-Based Probes: Fluorescent substrates to measure phosphatase activity
• CRISPR Screening: Genetic screens identify SYNJ2 synthetic lethal partners

Key Publications

See Also

• [SYNJ2 Gene](/proteins/synj2-protein)
• [Synaptic Vesicle Cycling Pathway](/mechanisms/synaptic-vesicle-cycling-pathway)
• [Synaptic Dysfunction Pathway](/mechanisms/synaptic-dysfunction-pathway)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [LRRK2 Pathway](/mechanisms/lrrk2-pathway)

External Links

• [UniProt: Q9QUH5](https://www.uniprot.org/uniprot/Q9QUH5)
• [GeneCards: SYNJ2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SYNJ2)
• [NCBI Gene: 8874](https://www.ncbi.nlm.nih.gov/gene/8874)

Background

The study of Synaptojanin 2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References